The Antibodiome—Mapping the Humoral Immune Response to HIV
2019
Purpose of Review
The design of an HIV vaccine remains an elusive but top priority. Data from the non-human primate model and the first moderately protective HIV vaccine trial (RV144) point to a role for qualitative changes in humoral immune functions in protection from infection. Here, we review the current understanding of the antibody response throughout HIV infection, the known correlates of protection, and current strategies to manipulate antibodies to put an end to the epidemic.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
121
References
5
Citations
NaN
KQI